The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant ... one of five pioneers to develop a large-scale production of the new anti-infective penicillin.

A legal research organization focused on public health says Abbott Laboratories' marketing of ... by the U.S. Food & Drug Administration. The production cuts were partially responsible for ...

Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of ...

Analyst Lee Hambright of Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), boosting the price target to ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit ...

A product made in Columbus reached a major milestone at the end of 2024. Ensure, a nutritional drink made by Abbott ...

Abbott Laboratories “purposely marketed” toddler milks to portray them as the next recommended step in a child’s diet – but the sugary drinks can actually cause health issues like obesity ...